Pear Therapeutics, Inc. reports

Company location: Boston, MA
Fiscal year end: 31 December

Pear Therapeutics, Inc. has filed 219 SEC EDGAR filings since 15 Dec 2020

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 201-219 of 219 matching filings.

Per page

25

Current page

9

8-K File 001-39969

8-K

Filing date: 24 May 2021
Reporting date: 21 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

NT 10-Q File 001-39969

NT 10-Q

Filing date: 18 May 2021
Reporting date: 31 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-39969

8-K

Filing date: 10 Feb 2021
Reporting date: 04 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-39969

8-K

Filing date: 04 Feb 2021
Reporting date: 01 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

424B2 File 333-252150

424B2

Filing date: 03 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-252150

EFFECT filing

Filing date: 01 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 01 Feb 2021
Reporting date: 01 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 01 Feb 2021
Reporting date: 01 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 01 Feb 2021
Reporting date: 01 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 01 Feb 2021
Reporting date: 01 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 01 Feb 2021
Reporting date: 01 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 01 Feb 2021
Reporting date: 01 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 01 Feb 2021
Reporting date: 01 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

S-1MEF File 333-252637

S-1MEF

Filing date: 01 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

CERT File 001-39969

CERT filing

Filing date: 01 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-A12B File 001-39969

8-A12B

Filing date: 01 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

S-1/A File 333-252150

S-1/A

Filing date: 26 Jan 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

S-1 File 333-252150

FORM S-1

Filing date: 15 Jan 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DRS File 377-03891

DRS filing

Filing date: 15 Dec 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .